What are the best treatments for Doose Syndrome?

TL;DR: Treatment for Doose Syndrome, or Myoclonic-Atonic Epilepsy (MAE), typically involves a combination of anti-seizure medications and specialized dietary therapies, such as the ketogenic diet. Because Doose Syndrome is often refractory to standard treatments, management must be highly personalized by a multidisciplinary neurology team to address the specific seizure types and developmental needs of the patient.

What are the first-line and pharmacological treatments for Doose Syndrome?

There is no single "cure-all" for Doose Syndrome, and initial treatment usually focuses on finding an effective anti-seizure medication (ASM) regimen. Valproate (Depakene, Depakote) is frequently considered a first-line medication for Doose Syndrome due to its broad-spectrum efficacy. However, because Doose Syndrome is characterized by drug-resistant seizures, clinicians often need to add adjunctive therapies. Commonly prescribed medications include levetiracetam (Keppra), topiramate (Topamax), lamotrigine (Lamictal), and clobazam (Onfi). In some cases, ethosuximide (Zarontin) is utilized specifically to target absence seizures, which are a common feature of this condition.

What are the non-pharmacological approaches to managing Doose Syndrome?

When medications alone fail to achieve seizure control, dietary therapies often become the cornerstone of treatment for Doose Syndrome. The ketogenic diet, which is high in fats and low in carbohydrates, has shown significant success in reducing seizure frequency in many children with this diagnosis. Beyond diet, other supportive interventions include:

• Vagus Nerve Stimulation (VNS): A device implanted to send mild pulses to the brain to help prevent seizures.


• Occupational and Physical Therapy: Critical for addressing the motor coordination and developmental delays frequently associated with Doose Syndrome.


• Speech Therapy: Essential for children experiencing language regression or delays.


• Neuropsychological Support: Helping families and patients navigate the cognitive and behavioral impacts of chronic epilepsy.

Which specialists should be on the care team?

Managing Doose Syndrome requires a coordinated, multidisciplinary approach to ensure the patient’s physical, cognitive, and emotional health are addressed. Your care team should ideally include:

1. Pediatric Epileptologist: A neurologist with specialized training in childhood epilepsy.


2. Registered Dietitian: Specifically trained in the medical administration of the ketogenic or modified Atkins diet.


3. Genetic Counselor: To help investigate potential underlying genetic contributors to the epilepsy.


4. Developmental Pediatrician: To monitor long-term growth, learning, and behavioral milestones.


5. Physical and Occupational Therapists: To manage motor function and daily living skills.

How does treatment effectiveness vary between patients?

Treatment response in Doose Syndrome is highly variable; what works for one child may be ineffective for another. While some children achieve seizure freedom with medication, others may require a combination of therapies or may continue to experience breakthrough seizures. It is important to note that 65 members of the DiseaseMaps community have shared their experiences with Doose Syndrome, highlighting the diverse range of outcomes and the necessity of trial-and-error in finding the right treatment protocol. Ongoing clinical trials continue to investigate new ASMs and neurostimulation techniques, offering hope for improved management strategies.

Next steps

• Consult with a board-certified pediatric epileptologist to review your current treatment plan.


• Discuss the potential benefits of the ketogenic diet with your neurology team.


• Connect with the 65 other community members on DiseaseMaps.org to share experiences and learn from others' treatment journeys.


• Keep a detailed seizure diary to track medication effectiveness and potential triggers.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for diagnosis and treatment decisions specific to your situation.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Myoclonic-astatic epilepsy.


• Orphanet: Myoclonic-atonic epilepsy of early childhood.


• OMIM (Online Mendelian Inheritance in Man): Epilepsy, childhood absence, with febrile seizures plus.


• The Charlie Foundation for Ketogenic Therapies: Resources on dietary management for epilepsy.